Cresco Labs appointed Edward Tilly to its Board of Directors, effective September 18, 2026. Tilly, the former Chairman and CEO of CBOE Global Markets, brings over 35 years of financial market experience to the company.
He will serve as an independent director and join the Audit Committee. This appointment expands the board to eight members.
The move aims to strengthen Cresco’s capital markets expertise ahead of potential U.S. federal cannabis regulation changes. Such reforms could provide the company with broader access to major U.S. stock exchanges.
Board Chairman Tom Manning highlighted Tilly’s experience in building and governing public market infrastructure as a key asset for the company’s next growth phase.